申请人:Bayer Aktiengesellschaft
公开号:US05646166A1
公开(公告)日:1997-07-08
The present invention relates to the new use of 1-alkyl-3,5-diacyl-1,4-dihydropyridines which are known in some cases, of the general formula (I) ##STR1## in which R.sup.1 to R.sup.4 have the meaning indicated in the description, processes for their preparation and their use as medicaments, as selective potassium channel modulators, in particular for the treatment of the central nervous system.
本发明涉及1-烷基-3,5-二酰基-1,4-二氢吡啶的新用途,该化合物在某些情况下已知,其一般式为(I)##STR1##其中R.sup.1至R.sup.4在说明中有所说明,以及它们的制备方法和它们作为药物的用途,作为选择性钾通道调节剂,特别是用于治疗中枢神经系统。